Pre-trial results

If customers can’t find it, it doesn’t exist. Clearly list and describe the services you offer. Also, be sure to showcase a premium service.

Having a big sale, on-site celebrity, or other event? Be sure to announce it so everybody knows and gets excited about it.

Are your customers raving about you on social media? Share their great stories to help turn potential customers into loyal ones.

Running a holiday sale or weekly special? Definitely promote it here to get customers excited about getting a sweet deal.

Have you opened a new location, redesigned your shop, or added a new product or service? Don't keep it to yourself, let folks know.

Customers have questions, you have answers. Display the most frequently asked questions, so everybody benefits.

Study Overview and Process

Sixteen pigs were divided into four subgroups (1, 2, 3, and 4) of four each.
On Day Zero, all sixteen pigs were injected with equal levels of Porcine Reproductive and Respiratory Syndrome (vPRRS) strain LHVA-93-3 which was then active in Eastern Canada.
Group 1 was left untreated.
Pigs in the remaining three groups each received one dose of Aptagenic™ A-505 (deemed most effective of 10 prototype Aptagenics™ produced for the study on a staggered timetable:
Group 2 was treated on day zero about 12 hours after infection.
Group 3 was treated on day one.
Group 4 was treated on Day two.